These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6778628)

  • 1. Complement activation by commercial allergen extracts of cereal grains.
    Olenchock SA; Mull JC; Major PC
    Clin Allergy; 1980 Jul; 10(4):395-404. PubMed ID: 6778628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro alternative and classical activation of complement by extracts of cotton mill dust: a possible mechanism in the pathogenesis of byssinosis.
    Mundie TG; Boackle RJ; Ainsworth SK
    Environ Res; 1983 Oct; 32(1):47-56. PubMed ID: 6617618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanisms of allergen-induced activation of the classical and lectin pathways of complement.
    Varga L; Szilágyi K; Lõrincz Z; Berrens L; Thiel S; Závodszky P; Daha MR; Thielens NM; Arlaud GJ; Nagy K; Späth P; Füst G
    Mol Immunol; 2003 May; 39(14):839-46. PubMed ID: 12686499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent complement consumption by Micropolyspora faeni.
    Marx JJ; Motszko C; Roberts RC
    Int Arch Allergy Appl Immunol; 1980; 62(2):133-41. PubMed ID: 6768678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activation of complement by isolated human heart subcellular membranes.
    Giclas PC; Pinckard RN; Olson MS
    J Immunol; 1979 Jan; 122(1):146-51. PubMed ID: 762412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
    Loos M; Bitter-Suermann D
    Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
    Garred P; Mollnes TE; Thorsteinsson L; Erlendsson K; Steinsson K
    Scand J Immunol; 1990 Jan; 31(1):59-64. PubMed ID: 2300790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation by pneumococci associated with acute otitis media.
    Prellner K
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP; Cooper NR
    J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
    J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-independent activation of C1 by type Ia group B streptococci.
    Eads ME; Levy NJ; Kasper DL; Baker CJ; Nicholson-Weller A
    J Infect Dis; 1982 Nov; 146(5):665-72. PubMed ID: 6752296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.